Session to Explore Unmet Patient Needs, Opportunities in Lung Cancer
Fred GebhartOn Sunday eight investigators—including Dr. Anne-Marie Baird and the Go2 Foundation’s Brittney Nichols, MPH—will present research on global challenges in lung cancer care during the “Barriers and Benefits” mini oral abstract session. Read more
STARS Program Trains Patients, Caregivers to be Research Advocates
Erin JungmeyerEach year, IASLC’s Supportive Training for Advocates on Research & Science program equips a new cohort with the skills needed to participate in thoracic oncology research. Read more
ELCC Session Offers Surgical Perspective in Context of Neoadjuvant Immunotherapy
Erin JungmeyerPresenter Dr. Alex Brunelli says neoadjuvant chemoimmunotherapy is a promising and well-tolerated treatment option in select patients with stage III NSCLC. Read more
Committee Update: Advocates Offer Unique Support to Members, Help Investigators Understand Patients
Erin JungmeyerPatient Advocates Committee Chair Jill Feldman said ensuring the patient voice is present in research helps to improve the work being done to reduce the burden of lung cancer worldwide. Read more
Passing of The Baton—On the Death of Patient Research Advocates
Angus Pratt, MBAPatient Perspective: We honor those we’ve lost by continuing their advocacy work, patient advocate Angus Pratt says. Read more
US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective
Matthew Z. Guo, BA+more
With no direct comparison to the standard of care and limited resources to review applications, researchers say they support the agency’s decision not to approve sintilimab. Read more
Early Palliative Care: A European Perspective
Florian Scotté, MD, PhDThe benefits of early palliative care have been proven. Could negative connotations of palliative care be impeding its adoption? Read more
When facing a grave illness, especially for the first time, many people are worried, frightened, and overwhelmed. They may have difficulty focusing their attention on daily tasks and experience skewed […] Read more
Pembrolizumab Plus Platinum-Doublet Chemotherapy and Concurrent Radiotherapy as First-Line Treatment for Unresectable, Locally Advanced Stage III NSCLC: The KEYNOTE-799 Trial in Perspective
Noemí Reguart+more
Approximately one-third of patients with NSCLC are diagnosed with unresectable, locally advanced (LA) stage III disease.1 Historically, the standard of care for these patients has been concurrent platinum-based chemotherapy with […] Read more
Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for Developing Countries
Andrés F. Cardona+more
Since December 2019, the world has been mired in a pandemic that has displaced other 21st-century health priorities for many populations. The social significance and speed of contagion from COVID-19 […] Read more